The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy.

[1]  Ying Jiang,et al.  The emerging role of PPAR-alpha in breast cancer. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  D. Tang,et al.  ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells , 2023, Scientific Reports.

[3]  W. Liu,et al.  Corylin inhibits the progression of Non-small cell lung cancer cells by regulating NF-κB signaling pathway via targeting p65. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  K. Nam,et al.  Ginkgolide B Suppresses TPA-induced Metastatic Potential in MCF-7 Human Breast Cancer Cells by Inhibiting MAPK/AP-1 Signaling , 2022, Biotechnology and Bioprocess Engineering.

[5]  Dongwei Yu,et al.  Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway. , 2022, Chemico-biological interactions.

[6]  M. Essand,et al.  ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression , 2022, Frontiers in Immunology.

[7]  C. Di,et al.  Mutant p53 in cancer: from molecular mechanism to therapeutic modulation , 2022, Cell Death & Disease.

[8]  Y. Seong,et al.  Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells , 2022, Cancers.

[9]  D. Miglioretti,et al.  Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis , 2022, Cancer.

[10]  J. Nemunaitis,et al.  NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer , 2022, Oncology Reviews.

[11]  M. Meselhy,et al.  Russelioside A, a Pregnane Glycoside from Caralluma tuberculate, Inhibits Cell-Intrinsic NF-κB Activity and Metastatic Ability of Breast Cancer Cells. , 2022, Biological & pharmaceutical bulletin.

[12]  I. Soerjomataram,et al.  Current and future burden of breast cancer: Global statistics for 2020 and 2040 , 2022, Breast.

[13]  M. J. Barroca,et al.  Corema album Leaves Mediate DNA Damage in Triple-Negative Breast Cancer Cells , 2022, Current issues in molecular biology.

[14]  M. Peifer,et al.  NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancer , 2022, bioRxiv.

[15]  L. Avalle,et al.  Shedding Light on NF-κB Functions in Cellular Organelles , 2022, Frontiers in Cell and Developmental Biology.

[16]  N. Delk,et al.  Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance , 2022, Cells.

[17]  Zhijian J. Chen,et al.  Liquid Phase Separation of NEMO Induced by Polyubiquitin Chains Activates NF-κB , 2022, Molecular cell.

[18]  L. Pusztai,et al.  CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression , 2022, Science Translational Medicine.

[19]  A. Kawiak,et al.  Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy , 2022, Cancers.

[20]  A. Islam,et al.  Phytochemicals targeting NF-κB signaling: Potential anti-cancer interventions , 2021, Journal of pharmaceutical analysis.

[21]  R. Malla,et al.  Tumor microenvironment pathways: Cross regulation in breast cancer metastasis , 2020, Genes & diseases.

[22]  H. Koo,et al.  Dual role of ERK2/NF-κB signaling in TRAIL sensitivity. , 2022, American journal of cancer research.

[23]  Hongbo Hu,et al.  NF‐κB signaling in inflammation and cancer , 2021, MedComm.

[24]  Aamir Ahmad,et al.  Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. , 2021, Seminars in cancer biology.

[25]  A. Chung,et al.  Antitumor Effects of Selenium , 2021, International journal of molecular sciences.

[26]  P. Elsinga,et al.  Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  Y. Lim,et al.  WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple‐negative breast cancer via NF‐κB activation , 2021, Molecular oncology.

[28]  A. Bisio,et al.  Radiation Resistance: A Matter of Transcription Factors , 2021, Frontiers in Oncology.

[29]  M. Cancino-Diaz,et al.  NF-κB and Its Regulators During Pregnancy , 2021, Frontiers in Immunology.

[30]  M. Tolba,et al.  Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. , 2021, Chemico-biological interactions.

[31]  N. Tanaka,et al.  MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade , 2021, Scientific Reports.

[32]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[33]  G. Aliev,et al.  The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives. , 2020, Seminars in cancer biology.

[34]  Wenjun Yang,et al.  Narasin inhibits tumor metastasis and growth of ERα-positive breast cancer cells by inactivation of the TGF-β/SMAD3 and IL-6/STAT3 signaling pathways , 2020, Molecular medicine reports.

[35]  G. Sethi,et al.  Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[36]  A. Rana,et al.  Transcription Factors in Cancer Development and Therapy , 2020, Cancers.

[37]  W. Rhee,et al.  Exosome-mediated Let7c-5p Delivery for Breast Cancer Therapeutic Development , 2020, Biotechnology and Bioprocess Engineering.

[38]  J. Harrell,et al.  New generation breast cancer cell lines developed from patient-derived xenografts , 2020, Breast Cancer Research.

[39]  Fan Wang,et al.  Thalidomide suppresses breast cancer tumor growth by inhibiting tumor-associated macrophage accumulation in breast tumor-bearing mice. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[40]  Yong Xu,et al.  Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review). , 2020, International journal of oncology.

[41]  Kunpeng Liu,et al.  TRIM25 Promotes TNF-α–Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2 , 2020, The Journal of Immunology.

[42]  Zhijie Liang,et al.  ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo. , 2019, Journal of biochemistry.

[43]  A. Regev,et al.  Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers , 2019, Proceedings of the National Academy of Sciences.

[44]  Liang Xu,et al.  Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis , 2019, EBioMedicine.

[45]  A. Letai,et al.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.

[46]  B. Qian,et al.  ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer , 2019, Breast Cancer Research and Treatment.

[47]  N. Hannett,et al.  Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains , 2018, Cell.

[48]  A. Sims,et al.  Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy , 2018, Clinical breast cancer.

[49]  F. J. Nicolás,et al.  SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression , 2018, Front. Endocrinol..

[50]  Libing Song,et al.  An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling. , 2018, Cancer research.

[51]  F. Mosaffa,et al.  Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors , 2018, Journal of cellular physiology.

[52]  Qi Wang,et al.  CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling , 2018, Cell Death & Disease.

[53]  Lin Zhao,et al.  Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling , 2018, Scientific Reports.

[54]  Myung‐Jin Park,et al.  Oct4 suppresses IR-induced premature senescence in breast cancer cells through STAT3- and NF-κB-mediated IL-24 production , 2018, International journal of oncology.

[55]  D. Frank,et al.  The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells1 , 2018, Neoplasia.

[56]  Richard L. Nolan,et al.  Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases , 2018, Pharmacological research.

[57]  A. Godwin,et al.  Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression , 2018, Cell Death & Disease.

[58]  Afshin Samali,et al.  RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells. , 2018, Biochemical and biophysical research communications.

[59]  L. Ren,et al.  Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines , 2018, Molecular medicine reports.

[60]  Shagufta,et al.  Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. , 2018, European journal of medicinal chemistry.

[61]  M. Brackstone,et al.  COX-2 induces oncogenic micro RNA miR655 in human breast cancer , 2018, Scientific Reports.

[62]  Mari Cleide Sogayar,et al.  The crossroads of breast cancer progression: insights into the modulation of major signaling pathways , 2017, OncoTargets and therapy.

[63]  Jae-Bong Park,et al.  Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB. , 2017, Free radical biology & medicine.

[64]  D. Pei,et al.  PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo , 2017, Journal of experimental & clinical cancer research : CR.

[65]  N. Vickers,et al.  Animal Communication: When I’m Calling You, Will You Answer Too? , 2017, Current Biology.

[66]  Shao-Cong Sun,et al.  NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.

[67]  A. Giuliano,et al.  Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer , 2017, Cell Communication and Signaling.

[68]  E. Moustafa,et al.  Synergistic effect of Ebselen and gamma radiation on breast cancer cells , 2017, International journal of radiation biology.

[69]  P. Chu,et al.  Designing Core-Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy. , 2017, ACS nano.

[70]  J. Frasor,et al.  A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy , 2017, Hormones and Cancer.

[71]  N. Aravindan,et al.  Inter- and intra-cellular mechanism of NF-kB-dependent survival advantage and clonal expansion of radio-resistant cancer cells. , 2017, Cellular signalling.

[72]  Hongsheng Wang,et al.  Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. , 2017, Cancer letters.

[73]  W. Klapper,et al.  Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma , 2017, Leukemia.

[74]  Youbin Li,et al.  Upconversion optical/magnetic resonance imaging-guided small tumor detection and in vivo tri-modal bioimaging based on high-performance luminescent nanorods. , 2017, Biomaterials.

[75]  S. Dietrich,et al.  Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells. , 2017, Cellular signalling.

[76]  N. Samadi,et al.  NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer , 2017, Breast Cancer.

[77]  G. Semenza,et al.  Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. , 2016, Trends in cancer.

[78]  J. Lee,et al.  The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment , 2016, Scientific Reports.

[79]  S. Woo,et al.  YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells , 2016, Oncotarget.

[80]  Xiaodong Wang,et al.  Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer , 2016, PLoS Comput. Biol..

[81]  T. Das,et al.  Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells. , 2016, Cancer research.

[82]  Maryam K. Mohammed,et al.  The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies , 2015, Laboratory Investigation.

[83]  Leif E. Peterson,et al.  Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes. , 2015, American journal of physiology. Heart and circulatory physiology.

[84]  I. Filippi,et al.  Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1α and NFκB Transcription Factors , 2015, Mediators of inflammation.

[85]  Y. Assaraf,et al.  Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[86]  R. Kaaks,et al.  Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg. , 2015, Journal of the National Cancer Institute.

[87]  P. Munster,et al.  Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours. , 2015, European journal of cancer.

[88]  Yuan Yuan,et al.  Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells. , 2015, Molecular medicine reports.

[89]  Flore Kruiswijk,et al.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.

[90]  T. Paull.  Mechanisms of ATM Activation. , 2015, Annual review of biochemistry.

[91]  M. Stang,et al.  IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition , 2015, Cancer biology & therapy.

[92]  T. Das,et al.  Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin. , 2015, Translational research : the journal of laboratory and clinical medicine.

[93]  Albert C. Chen,et al.  Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.

[94]  J. Dannenberg,et al.  Sumoylation of HDAC2 promotes NF-κB-dependent gene expression , 2015, Oncotarget.

[95]  M. El-Shinawi,et al.  Positive lymph‐node breast cancer patients – activation of NF‐κB in tumor‐associated leukocytes stimulates cytokine secretion that promotes metastasis via C‐C chemokine receptor CCR7 , 2015, The FEBS journal.

[96]  Ruiwen Zhang,et al.  Targeting the NFκB signaling pathways for breast cancer prevention and therapy. , 2014, Current medicinal chemistry.

[97]  D. Figeys,et al.  β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer , 2014, Cell Death and Differentiation.

[98]  B. Karlan,et al.  FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer , 2014, Annals of Surgical Oncology.

[99]  A. Oro,et al.  Advanced treatment for basal cell carcinomas. , 2014, Cold Spring Harbor perspectives in medicine.

[100]  Hong Yang,et al.  Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation , 2014, PloS one.

[101]  Q. Li,et al.  The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model , 2014, Oncogene.

[102]  K. Noguchi,et al.  Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics , 2014, Pharmacogenomics and personalized medicine.

[103]  F. Vizoso,et al.  Clinical Significance of Toll-like Receptor 3, 4, and 9 in Gastric Cancer , 2014, Journal of immunotherapy.

[104]  A. Baldwin,et al.  Canonical and Non-Canonical NF-κB Signaling Promotes Breast Cancer Tumor-Initiating Cells , 2013, Oncogene.

[105]  D. Dréau,et al.  Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling , 2014, Angiogenesis.

[106]  J. Shay,et al.  Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways , 2014, Breast Cancer Research.

[107]  J. Vadgama,et al.  Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells , 2013, PloS one.

[108]  W. Jiang,et al.  Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer. , 2013, Biochimica et biophysica acta.

[109]  S. Grivennikov,et al.  Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer , 2013, Breast Cancer Research.

[110]  Junnian Zheng,et al.  PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell , 2013, Tumor Biology.

[111]  Vassilis G Gorgoulis,et al.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. , 2013, Cancer cell.

[112]  D. Sarkar,et al.  Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients , 2013, Indian Journal of Surgical Oncology.

[113]  Sandra A O'Toole,et al.  The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy , 2013, Breast Cancer Research.

[114]  Paul G. Thomas,et al.  Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection , 2013, Nature Immunology.

[115]  J. Yager,et al.  Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis , 2013, Steroids.

[116]  Ian Krop,et al.  Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors , 2013, Clinical Cancer Research.

[117]  P. Fisher,et al.  Targeting the Bcl-2 family for cancer therapy , 2013, Expert opinion on therapeutic targets.

[118]  B. Salimath,et al.  Crosstalk between VEGF and novel angiogenic protein regulates tumor angiogenesis and contributes to aggressiveness of breast carcinoma. , 2013, Cellular signalling.

[119]  P. Altevogt,et al.  EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. , 2012, Carcinogenesis.

[120]  W. Hahn,et al.  IκB Kinase ε Phosphorylates TRAF2 To Promote Mammary Epithelial Cell Transformation , 2012, Molecular and Cellular Biology.

[121]  A. Tomassetti,et al.  Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer , 2012, Oncogene.

[122]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[123]  P. Pauwels,et al.  The interaction between ER and NFκB in resistance to endocrine therapy , 2012, Breast Cancer Research.

[124]  M. Wicha,et al.  Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. , 2012, Molecular cell.

[125]  Wenqiang Cao,et al.  Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism. , 2012, ACS nano.

[126]  Hong Wu,et al.  A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. , 2012, Cancer cell.

[127]  Wei-Guo Zhu,et al.  Surf the Post-translational Modification Network of p53 Regulation , 2012, International journal of biological sciences.

[128]  Hirohito Yamaguchi,et al.  Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. , 2012, Cancer research.

[129]  D. Santini,et al.  Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells , 2012, Cell Death and Differentiation.

[130]  N. Perkins,et al.  The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.

[131]  L. Wiesmüller,et al.  NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes , 2011, Nucleic acids research.

[132]  Tao He,et al.  Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms , 2011, Cell Research.

[133]  Melissa G. Piper,et al.  M-CSF Induces Monocyte Survival by Activating NF-κB p65 Phosphorylation at Ser276 via Protein Kinase C , 2011, PLoS ONE.

[134]  Genhong Cheng,et al.  Non‐canonical NF‐κB signaling activation and regulation: principles and perspectives , 2011, Immunological reviews.

[135]  A. Gulino,et al.  Thioredoxin stimulates MMP‐9 expression, de‐regulates the MMP‐9/TIMP‐1 equilibrium and promotes MMP‐9 dependent invasion in human MDA‐MB‐231 breast cancer cells , 2011, FEBS letters.

[136]  L. Ramalho,et al.  The role of tumor hypoxia in MUC1-positive breast carcinomas , 2011, Virchows Archiv.

[137]  S. Balasubramanian,et al.  The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. , 2011, Nature chemistry.

[138]  Laura J. Esserman,et al.  Leukocyte composition of human breast cancer , 2011, Proceedings of the National Academy of Sciences.

[139]  Mithat Gönen,et al.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.

[140]  D. Philpott,et al.  Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands , 2011, European journal of immunology.

[141]  Hyung Gyun Kim,et al.  Metallothionein‐2A overexpression increases the expression of matrix metalloproteinase‐9 and invasion of breast cancer cells , 2011, FEBS letters.

[142]  Yan Zhou,et al.  The Codon 72 Polymorphism of p53 Regulates Interaction with NF-κB and Transactivation of Genes Involved in Immunity and Inflammation , 2011, Molecular and Cellular Biology.

[143]  F. Vizoso,et al.  Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence , 2011, Cancer Immunology, Immunotherapy.

[144]  E. Sen,et al.  Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma , 2011, Journal of Molecular Medicine.

[145]  I. Filippi,et al.  Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α. , 2010, European journal of cancer.

[146]  K. Kirito,et al.  NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma. , 2010, Experimental hematology.

[147]  J. Asara,et al.  Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. , 2010, Genes & development.

[148]  J. Li,et al.  Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[149]  H. Ban,et al.  Suppression of hypoxia-induced HIF-1alpha accumulation by VEGFR inhibitors: Different profiles of AAL993 versus SU5416 and KRN633. , 2010, Cancer letters.

[150]  M. Karin,et al.  Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation. , 2010, Molecular cell.

[151]  J. Frasor,et al.  Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements*♦ , 2010, The Journal of Biological Chemistry.

[152]  D. Vordermark.  Hypoxia-specific targets in cancer therapy: role of splice variants , 2010, BMC medicine.

[153]  C. Clarke,et al.  Progesterone induces adult mammary stem cell expansion , 2010, Nature.

[154]  J. Visvader,et al.  Control of mammary stem cell function by steroid hormone signalling , 2010, Nature.

[155]  W. Su,et al.  Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX , 2010, Virchows Archiv.

[156]  D Saur,et al.  Cross talk between stimulated NF-κB and the tumor suppressor p53 , 2010, Oncogene.

[157]  G. Sethi,et al.  Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. , 2010, Biochimica et biophysica acta.

[158]  C. Brisken,et al.  Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland , 2010, Proceedings of the National Academy of Sciences.

[159]  M. Tkach,et al.  Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation , 2010, Breast Cancer Research and Treatment.

[160]  J. Inoue,et al.  Constitutive activation of nuclear factor‐κB is preferentially involved in the proliferation of basal‐like subtype breast cancer cell lines , 2009, Cancer science.

[161]  G. Sonenshein,et al.  Inhibition of RelB by 1,25‐dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation , 2009, Journal of cellular physiology.

[162]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[163]  A. Paradiso,et al.  Circulating hTERT DNA in early breast cancer. , 2009, Anticancer research.

[164]  Zuoren Yu,et al.  Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. , 2009, The American journal of pathology.

[165]  Hua Yu,et al.  Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. , 2009, Cancer cell.

[166]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[167]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[168]  J. Pollard,et al.  Macrophages define the invasive microenvironment in breast cancer , 2008, Journal of leukocyte biology.

[169]  S. Miyamoto,et al.  Induction of a pro‐apoptotic ATM–NF‐κB pathway and its repression by ATR in response to replication stress , 2008, The EMBO journal.

[170]  Hongbing Shen,et al.  A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women. , 2008, Carcinogenesis.

[171]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[172]  R. Greil,et al.  A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[173]  Zhong-ying Shen,et al.  Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas , 2007, Oncogene.

[174]  K. Horiuchi,et al.  Cell Surface Colony-Stimulating Factor 1 Can Be Cleaved by TNF-α Converting Enzyme or Endocytosed in a Clathrin-Dependent Manner1 , 2007, The Journal of Immunology.

[175]  E. van Marck,et al.  NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation , 2007, British Journal of Cancer.

[176]  Eric S. Lander,et al.  Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.

[177]  T. Kietzmann,et al.  Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .

[178]  V. Rotter,et al.  Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. , 2007, Cancer research.

[179]  S. Badve,et al.  NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.

[180]  M. Bissell,et al.  Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.

[181]  J. Pollard,et al.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.

[182]  S. McDougall,et al.  Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. , 2006, Journal of theoretical biology.

[183]  E. van Marck,et al.  Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding , 2006, Clinical Cancer Research.

[184]  R. Tibbetts,et al.  Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.

[185]  G. Reynolds,et al.  Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth , 2005, Oncogene.

[186]  R. Kreienberg,et al.  Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro , 2005, Angiogenesis.

[187]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[188]  P. Barker,et al.  Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. , 2005, Cancer research.

[189]  Urs Eppenberger,et al.  Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers , 2005 .

[190]  Tieli Wang,et al.  Co-activation of ERK, NF-κB, and GADD45β in Response to Ionizing Radiation* , 2005, Journal of Biological Chemistry.

[191]  Andreas Sommer,et al.  NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression , 2004 .

[192]  W. Friedrichs,et al.  NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[193]  G. Hortobagyi,et al.  Inflammatory breast carcinoma: the sphinx of breast cancer research. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[194]  M. Karin,et al.  NF-κB in Mammary Gland Development and Breast Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.

[195]  T. Gilmore,et al.  The Rel/NF-κB/IκB Signal Transduction Pathway and Cancer , 2004 .

[196]  D. W. Kim,et al.  Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors , 2003, Molecular and Cellular Biology.

[197]  David C. Lee,et al.  TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological Convertase , 2003, Annals of the New York Academy of Sciences.

[198]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[199]  M. Jasin.  Homologous repair of DNA damage and tumorigenesis:the BRCA connection , 2002, Oncogene.

[200]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[201]  C. Chiang,et al.  NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. , 2002, Military medicine.

[202]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[203]  M. Meltz,et al.  Effect of melatonin on cell growth, metabolic activity, and cell cycle distribution , 2001, Journal of pineal research.

[204]  W. Funkhouser,et al.  Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.

[205]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[206]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[207]  Céline Gélinas,et al.  Rel/NF‐κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors , 1999, The EMBO journal.

[208]  F. Martinon,et al.  Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 , 1998, Current Biology.

[209]  V. Dixit,et al.  RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.

[210]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[211]  C. Leonetti,et al.  Bcl‐2 overexpression enhances the metastatic potential of a human breast cancer line , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[212]  G. Sledge,et al.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.

[213]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[214]  M. Meltz,et al.  Induction of transcription of "immediate early genes" by low-dose ionizing radiation. , 1995, Radiation research.

[215]  M. Meltz,et al.  Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. , 1994, Radiation research.